![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/4745 | |
A61K 31/454 | |||
A61K 31/519 | |||
A61K 31/573 | |||
A61K 31/664 | |||
A61K 31/704 | |||
A61P 43/00 | |||
A61P 35/00 | |||
A61K 45/06 | |||
A61K 31/44 | |||
A61K 31/506 | |||
A61K 31/5377 | |||
A61P 35/02 |
(11) | Patento numeris | 3325014 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16744650.9 |
Europos patento paraiškos padavimo data | 2016-07-19 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-05-30 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-19 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2016/042905 |
Data | 2016-07-19 |
(87) | Numeris | WO 2017/015262 |
Data | 2017-01-26 |
(30) | Numeris | Data | Šalis |
201562194367 P | 2015-07-20 | US |
(72) |
LICHENSTEIN, Henri, US
ROTHBERG, Jonathan, M., US
GAYLE, Sophia, US
BEEHARRY, Neil, US
BECKETT, Paul, US
LANDRETTE, Sean, US
CONRAD, Chris, US
XU, Tian, US
|
(73) |
AI Therapeutics, Inc.,
530 Old Whitfield Street, Guilford CT 06437,
US
|
(54) | METHODS FOR TREATING CANCER USING APILIMOD |
METHODS FOR TREATING CANCER USING APILIMOD |